ISB Gets $3.4M NIH Extension for Cancer Genomics Cloud


FOR IMMEDIATE RELEASE
ISB Receives $3.4 Million Extension to NIH Contract to Continue Development of ‘Cancer Genomics Cloud’ with Google and CSRA
SEATTLE, Oct. 21, 2016 – Institute for Systems Biology (ISB) has received a $3.4 million, one-year extension to an existing federally-funded contract from the National Cancer Institute (NCI), National Institutes of Health (NIH). This follows the completion of the initial two-year, $6.5 million contract during which ISB developed the ISB-CGC, a cloud-based platform that serves as a large-scale data repository and includes both interactive and programmatic interfaces, as well as the computational infrastructure necessary to carry out cancer genomics research at an unprecedented scale. With the additional funding, the ISB-CGC team, which includes partners at Google, Inc., and CSRA, will be able to extend the platform to include new data sets and new data types, in particular diagnostic images and proteomics data.
ISB-CGC already includes over 1 petabyte (PB) of data from The Cancer Genome Atlas (TCGA) project. The data and tools that the ISB-CGC platform provide, together with the compute power of the Google Cloud, have made TCGA data more accessible and more usable than ever before. The amount of data hosted by ISB-CGC will more than double during the extension year as additional data from the NCI Genomic Data Commons (GDC) is added to the current data set.
The NCI also awarded extensions to the Broad Institute and Seven Bridges Genomics.
FUNDING: This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261201400007C
ABOUT INSTITUTE FOR SYSTEMS BIOLOGY: The Institute for Systems Biology is a nonprofit biomedical research organization based in Seattle, Washington. It was founded in 2000 by systems biologist Leroy Hood, immunologist Alan Aderem, and protein chemist Ruedi Aebersold. ISB was established on the belief that the conventional models for exploring and funding breakthrough science have not caught up with the real potential of what is possible today. ISB serves as the ultimate environment where scientific collaboration stretches across disciplines and across academic and industrial organizations, where our researchers have the intellectual freedom to challenge the status quo, and where grand visions for breakthroughs in human health inspire a collective drive to achieve the seemingly impossible. Our core values ensure that we always keep our focus on the big ideas that eventually will have the largest impact on human health. ISB is an affiliate of Providence Health & Services.
Media contact:
Hsiao-Ching Chou
Director of Communications
Institute for Systems Biology
hchou@systemsbiology.org
Related Articles
-
TCGA, ISB Researchers Identify Potential Drug Targets for Leading Form of Deadly Liver Cancer
June 19, 2017 Researchers in ISB’s Shmulevich Lab and their colleagues in The Cancer Genome Atlas Research Network performed the first large-scale, multi-platform analysis of hepatocellular carcinoma, the predominant form of liver cancer. Study was published on June 15, 2017, in the journal Cell. 3 Bullets: Liver cancer is the second most common cause of death from cancer worldwide. ISB researchers and colleagues from The Cancer Genome Atlas Research Network…
Read More -
Former Undergrad Intern Publishes Algorithm in PLOS Computational Biology
Posted March 1, 2017 In a study published in PLoS Computational Biology, researchers at Institute for Systems Biology (ISB) have developed a multiscale mutation clustering algorithm (M2C) that identifies variable length regions with high mutation density in cancer genes. The M2C algorithm was developed by William Poole (first author on the paper), who started as a summer intern in 2013 as part of ISB’s Center for Systems Biology internship program….
Read More -
Sanger Institute’s COSMIC database expands cancer cloud capabilities at the Institute for Systems Biology
The Wellcome Trust Sanger Institute released this news on Feb. 20, 2017. See original release… FOR IMMEDIATE RELEASE The Wellcome Trust Sanger Institute’s Catalog of Somatic Mutations in Cancer (COSMIC) team announces a new agreement to provide their data to the U.S.-based Institute for Systems Biology (ISB). COSMIC is an expert-curated cancer mutation database, and is the world’s largest and most comprehensive resource for exploring the impact of somatic mutations…
Read More
-
Comprehensive study of esophageal cancer reveals several molecular subtypes, provides new insight into increasingly prevalent disease
The Cancer Genome Atlas Research Network recommends clinical trials organizers and drug manufacturers focus on newly discovered molecular subtypes GRAND RAPIDS, Mich., Jan. 4, 2017 –– A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esophageal cancer differ markedly in their molecular characteristics and should be considered separate diseases. The study, published today in Nature from The…
Read More -
Vice President Biden Gives Cancer Moonshot Update
This week, Vice President Biden delivered an extensive update on the progress of the Cancer Moonshot initiative. ISB was mentioned in relation to the Cancer Genomics Cloud project. Learn more about ISB CGC at isb-cgc.org. Excerpt from the official White House press release: Official White House press release Full Cancer Moonshot Report Puget Sound Business Journal article
Read More -
A Landscape of Pharmacogenomic Interactions in Cancer
The journal Cell published a study today (July 7) about the integrated analysis of drug response in 1,001 cancer cell lines. This study was undertaken by a large international group of researchers including ISB Senior Research Scientist Theo Knijnenburg. The researchers integrated heterogeneous molecular data of 11,215 tumors and 1,001 cell lines in order to study the drug response of these cell lines to 265 anti-cancer drugs. They uncovered numerous…
Read More
-
Systems Biology Digs Deep, Aims High
Dr. Ilya Shmulevich was recently interviewed for the following article in Genetic Engineering & Biotechnology News. Read more here.
Read More -
New Publication in ‘Cancer Cell’
As part of The Cancer Genome Atlas project, the Shmuelvich Lab and colleagues published a paper in the journal Cancer Cell related to the rare cancer adrenocortical carcinoma. Read the summary: 3 Bullets: Adrenocortical carcinoma (ACC) is a rare, under-researched endocrine cancer with limited therapeutic options and overall poor outcome. TCGA researchers performed comprehensive analysis of 91 ACC samples to gain better understanding of potential genetic causes of the cancer….
Read More -
In the News: Basketball and Biology
Congratulations to Dr. Nyasha Chambwe on being featured in the May 20 issue of Puget Sound Business Journal’s “People in Research” column. The profile reveals Dr. Chambwe’s path to ISB, starting with a full-ride scholarship to Jackson State University. She has been working on a study on pre-term birth and soon will be moving to projects related to glioblastoma and leukemia. Read the PSBJ article… Photo above: Dr. Nyasha Chambwe,…
Read More
-
Using Google Cloud Platform to Give Researchers Easier Access to Cancer Data
ISB’s Dr. Ilya Shmulevich attended Google Cloud Platform’s GCPNext conference in San Francisco and presented on ISB’s Cancer Genomics Cloud project. He explains how his team used GCP to create better access for a broad range of researchers to cancer genomics data (from The Cancer Genomics Atlas) and the tools with which to explore that data. Watch Dr. Shmulevich’s talk below.
Read More -
ISB’s Cancer Genomics Cloud Team Launches BigQuery Platform
Genomeweb published an article on the Cancer Genomics Cloud pilots. Learn more about ISB’s CGC project. PDF: Cancer Genomics Cloud Pilot Developers Provide Update, Open Up Platforms for Early Testing | GenomeWeb NEW YORK (GenomeWeb) – The developers of the three proposals selected by the National Cancer Institute for the Cancer Genomics Cloud pilots — an effort to build sustainable computing infrastructure for analyzing omics data from the Cancer Genome…
Read More -
The Women of ISB: Phyliss Lee, Software Engineer
Name: Phyliss Lee Lab: Shmulevich Research: I help create websites and pages for the Cancer Genomics Cloud Pilot Project. The tools that I’m building will not only help scientists gather petabytes of cancer genomic data faster, but will also help them run analyses and visualize the data graphically. What I’m building has the potential to reach millions of people. Working at ISB: What I like about being in science is…
Read More